Comprehensive Characterization of Anti-HLA and Non-HLA Antibodies in Patients on Kidney Transplant Waiting List and Evaluation of Their Impact on Alloimmunization Risk and Dialysis Treatment
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212103 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Aida Mujić Franić und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Tissue Typing, Clinical Hospital Center Rijeka, 51000 Rijeka, Croatia. Hauptthemen laut MEDLINE: Kidney Transplantation, HLA Antigens, Waiting Lists. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Alloimmunization remains a major obstacle to successful kidney transplantation, mainly due to the formation of anti-HLA antibodies. In recent years, non-HLA antibodies have emerged as additional immunologic factors that can potentially contribute to graft rejection. The aim of this study was to investigate the prevalence and specificity of both anti-HLA and non-HLA antibodies in patients with end-stage renal disease on a waiting list for kidney transplantation. Serum samples from 74 patients were analyzed using complement-dependent cytotoxicity and solid-phase assays. IgG anti-HLA antibodies were identified in 43.2% of participants, while IgG non-HLA antibodies were detected in 91.9%. The most frequent non-HLA antibodies included anti-ENO1 (28.4%), anti-FIBR1 (23.0%) and anti-PRKCZ (23.0%). A significant difference was found between the number of distinct IgG anti-HLA and IgG non-HLA antibody specificities. However, no significant correlation was found between the number of IgG non-HLA antibody specificities and previous alloimmunization events or dialysis treatments. These results suggest that non-HLA antibodies, although often overlooked, can sometimes play a critical role in transplant outcomes. Routine testing for non-HLA antibodies, in addition to mandatory anti-HLA antibody screening and identification, could improve immunologic risk assessment in transplant patients and post-transplant care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Tissue Typing, Clinical Hospital Center Rijeka, 51000 Rijeka, Croatia.
- School of Medicine, University of Mostar, 88000 Mostar, Bosnia and Herzegovina.
- Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
- Department of Medicinal Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.
ORCID-Profile: Marko Lilić, Nataša Katalinić, Ljubica Glavaš-Obrovac
Zitieren
APA
Mujić Franić, A., Lilić, M., Katalinić, N., & Glavaš-Obrovac, L. (2024). Comprehensive Characterization of Anti-HLA and Non-HLA Antibodies in Patients on Kidney Transplant Waiting List and Evaluation of Their Impact on Alloimmunization Risk and Dialysis Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212103
Vancouver
Mujić Franić A, Lilić M, Katalinić N, Glavaš-Obrovac L. Comprehensive Characterization of Anti-HLA and Non-HLA Antibodies in Patients on Kidney Transplant Waiting List and Evaluation of Their Impact on Alloimmunization Risk and Dialysis Treatment. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212103
BibTeX
@article{MujiFrani2024,
author = {Mujić Franić, Aida and Lilić, Marko and Katalinić, Nataša and Glavaš-Obrovac, Ljubica},
title = {Comprehensive Characterization of Anti-HLA and Non-HLA Antibodies in Patients on Kidney Transplant Waiting List and Evaluation of Their Impact on Alloimmunization Risk and Dialysis Treatment},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212103}
}
EUVIMED